bd.com (BDX): Total Debt to Capital

Becton, Dickinson and Company - graphic logo of issuer BDX

Becton Dickinson & Co (BDX) is implementing ESG standards by minimizing harmful plastics and optimizing sterilization. The manufacturer is updating polymers and transitioning to recyclable syringe packaging. The company's debt-to-equity ratio demonstrates financial stability, where the 0.64 mark reflects the current level of indebtedness. Geopolitical risks remain minimal, as the supply of humanitarian instruments is protected from trade embargoes.

BDX: bd.com Total Debt to Capital Coefficient 07/04/2022 - 10/30/2026
Finished products of Becton Dickinson & Co

This ratio determines the extent of the business's dependence on borrowed funds relative to its equity. The history of the company's financial leverage visualizes the dynamics of its debt load and financial stability. The metric is calculated as the ratio of total liabilities to net asset value. For Becton Dickinson & Co (BDX), moderate leverage is justified by stable demand for medical consumables. High FDA regulatory barriers ensure predictable cash flows for debt servicing.

Competitor analysis for Becton Dickinson & Co

ISRG (Intuitive) - Total Debt to Capital|Debt to Capital Danaher Corporation DHR|Total Debt to Capital STE|West Pharma Corp - Debt to Equity Ratio|Total Debt to Capital BAX (Baxter International)|Total Debt to Capital Coefficient masimo.com (MASI)|Stevanato Group - Total Debt to Capital|Teleflex Inc. (TFX) - Total Debt to Equity Ratio|MMSI: Total Debt to Capital|Nobel Biocare (NVST) - Total Debt to Capital|Debt to Equity ICU Medical, Inc.|Debt to Equity XRAY|Total Debt to Equity Ratio LMAT (LeMaitre Vascular)|ATRC (AtriCure Inc) - All Debt to Shareholders' Equity Ratio|Total Debt to Capital STAA (STAAR Surgical Corp)|Total Debt to Capital Coefficient ChromaDex (NAGE)|ZIMV - Debt to Equity|ANGO (angiodynamics.com) - Debt to Equity Ratio|Cerus (CERS) - Debt to Equity|TKNO - Total Debt to Capital Coefficient|Total Debt to Equity Ratio MGRM|STSS (Sharps Tech) - Aggregate Debt to Capital|Debt to Equity InfuSystem Holdings (INFU)|UTMD (utahmed.com) - All Debt to Shareholders' Equity Ratio|KORU Medical - Total Debt to Equity Ratio|Total Debt to Capital Nyxoah SA NYXH|MBOT - Debt to Equity|Pro-Dex Inc. (PDEX) - Total Debt to Equity Ratio|ZTEK: Total Debt to Capital|Debt to Capital elutia.com (ELUT)|Debt to Equity Milestone Scientific Inc.|Debt to Equity Ratio NXGL (NEXGEL Inc.)|Total Debt to Equity Ratio RVP (Retractable Technologies)|Aggregate Debt to Capital HBIO|Debt to Equity Femasys Inc. FEMY|Total Debt to Capital Coefficient Meihua Medical Technologies (MHUA)|Predictive Oncology Corp - Total Debt to Capital|CJMB: Debt to Equity|ATRI: Total Debt to Capital|Debt to Capital NeuroMetrix Corporation (NURO)